XY0YX37Extracorporeal Introduction of Nafamostat Anticoagulant, New Technology Group 7
- Billable / Specific Code
XY0YX37 is a billable ICD-10-PCS procedure code for Extracorporeal Introduction of Nafamostat Anticoagulant, New Technology Group 7. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products. The Alphabetic Index lists this code under Nafamostat Anticoagulant. In AHRQ's Clinical Classifications Software (CCSR), this procedure falls under Administration of therapeutic substances, NEC.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | Y | Extracorporeal |
| 3 | Operation | 0 | Introduction |
| 4 | BodyPart | Y | Extracorporeal |
| 5 | Approach | X | External |
| 6 | Device/Substance/Technology | 3 | Nafamostat Anticoagulant |
| 7 | Qualifier | 7 | New Technology Group 7 |
In the ICD-10-PCS Alphabetic Index
The FY 2027 ICD-10-PCS Alphabetic Index refers to XY0YX37 as Nafamostat Anticoagulant. These index entries lead to this code:
To code nafamostat anticoagulant, open the FY 2027 ICD-10-PCS Alphabetic Index at Nafamostat Anticoagulant. The entry lists XY0YX37 directly as a complete, billable code.
Clinical Classification (CCSR)
AHRQ groups this procedure code into these clinical categories.
Similar Procedure Codes
Questions About XY0YX37
Is XY0YX37 a billable code?
Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Extracorporeal Introduction of Nafamostat Anticoagulant, New Technology Group 7 on inpatient claims from October 1, 2026 through September 30, 2027.
What is the ICD-10-PCS code for nafamostat Anticoagulant?
The ICD-10-PCS Alphabetic Index lists Nafamostat Anticoagulant under code XY0YX37, Extracorporeal Introduction of Nafamostat Anticoagulant, New Technology Group 7, billable on inpatient claims in fiscal year 2027.
What do the characters in XY0YX37 mean?
The code breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character Y is the Body System (Extracorporeal); the 3rd character 0 is the Operation (Introduction); the 4th character Y is the BodyPart (Extracorporeal); the 5th character X is the Approach (External); the 6th character 3 is the Device/Substance/Technology (Nafamostat Anticoagulant); the 7th character 7 is the Qualifier (New Technology Group 7).
